Clinical trial
A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation
NCT06013514 is registered in ClinicalTrials.gov with GCA (Eurosilicone) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation
- Lead sponsor
- GCA (Eurosilicone)
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2024
- Completion date
- September 30, 2038
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast augmentation, breast implants, breast reconstruction, breast reconstruction after mastectomy, breast reconstruction following mastectomy, breast reconstruction surgery, breast reconstruction with silicone implants, breast revision